The FDA has approved the use of duloxetine (Cymbalta), a non-narcotic, to treat chronic musculoskeletal pain, including low back pain and osteoarthritis, the agency announced on Thursday.
The drug was previously approved as maintenance therapy in major depression and to treat generalized anxiety disorder, diabetic peripheral neuropathy, and fibromyalgia. The manufacturer says it is uncertain how duloxetine relieves pain, but it is believed to increase activity of serotonin and norepinephrine in the central nervous system.
Duloxetine's label includes a warning about the risk for increased suicidality among children, adolescents, and young adults.
Subscribe to:
Post Comments (Atom)
The drug was previously approved as maintenance therapy in major depression and to treat generalized anxiety disorder, diabetic peripheral neuropathy, and fibromyalgia
ReplyDelete